HiLIFE is regulated by University regulations and HiLIFE-specific Rules of Procedure (pdf). Director is responsible for HiLIFE strategic plans, overall budget and human resources plan, and overseeing organization of evaluation of HiLIFE activities by HiLIFE Scientific Council. The Board, also nominated by the Rector, together with the director develops Institute's activities in accordance with the University’s strategy and recommendations of the Scientific Council that evaluates HiLIFE activities and organization in the context of the university, and provides recommendations on future plans and scientific directions.
HiLIFE contains the Institute for Molecular Medicine Finland FIMM, Institute of Biotechnology (BI) and Neuroscience Center (NC) as units. Unit (BI/FIMM/NC) directors are responsible for their unit’s daily operations. Management team composed of HiLIFE director, unit directors, 1-4 experts on HiLIFE’s umbrella activities and the Head of administration supports the director in preparing, implementing, and monitoring matters and decisions, and in internal and external communication and collaboration.
HiLIFE’s leadership and staff are supported by University Services so that academic community can focus on research, teaching, studying and public engagement.
HiLIFE Director Jari Koistinaho has overall responsibility of operations according to the University Regulations and HiLIFE Rules of Procedure and prepares matters for the Board. Jari's research focuses on modelling neurological and psychatric disorders using human iPSC-based cell model in vitro and in vivo.
Mark Daly was appointed the FIMM Director with effect from February 1, 2018. He joined FIMM from the Broad Institute of MIT and Harvard and Massachusetts General Hospital. He is a distinguished scientist who has made major contributions to human genetics and genomics during his 20-year career.
To contact Mark Daly, please e-mail to: firstname.lastname@example.org, or contact Susanna Rosas.
Professor Samuli Ripatti has been appointed as Vice Director of the Institute for Molecular Medicine Finland (FIMM) for the period 1 May 2019 – 31 December 2022.
The Vice Director supports the FIMM Director in the development of FIMM as a whole, and in the absence or disqualification of the director acts as his or her deputy.
Samuli Ripatti is a Professor of Biometry at the Faculty of Medicine of the University of Helsinki and a Scholar at the Broad Institute of MIT and Harvard in Cambridge, MA, USA. Furthermore, he is the director of the Academy of Finland Centre of Excellence in Complex Disease Genetics. His research group studies genetic variation in the Finnish population and its effects on common complex disease risks and management. His research focuses in particular on cardiometabolic diseases as models to learn about disease mechanisms and genomic strategies for diagnoses and prevention. Samuli Ripatti has published over 250 articles that have been cited over 26,000 times. He is also currently chairing Doctoral Programmes in Biomedicine and Population Health.
To contact Samuli Ripatti, please e-mail or call to Sari Kivikko.
Juha Huiskonen is the director of the Institute of Biotechnology and Professor of Structural Biology.
Huiskonen’s research group - Laboratory of Structural Biology (LSB) – aims at understanding the structure and function of biological macromolecules and their complexes, such as molecular machines and viruses.
To contact Juha Huiskonen, please email to email@example.com
Maria Vartiainen is a research director at the Institute of Biotechnology and the scientific head of the Light Microscopy Unit (LMU) at BI.
Vartiainen’s research group studies the mechanisms that mediate the dynamic organization of the cell nucleus, with special emphasis on the role of actin in this process.
P.O. Box 21, Haartmaninkatu 3
FI-00014 University of Helsinki
Phone: +358 50 4484 742
Biomedicum 1, room B225b
FI-00014 University of Helsinki
According to the Rules of Procedure the board consists of 5-9 members representing high quality research. 1-2 members represent interaction partners of the university. HiLIFE personnel selects one member and a personal deputy. Doctoral students at the University of Helsinki select one member and a personal deputy for a two year term.
HiLIFE Board 1.8.2020-31.7.2024
The HiLIFE Scientific Council supports the HiLIFE Board and leadership in developing activities and scientific directions. The Council is appointed for four year terms and consists of 8-10 external internationally accomplished life science area researchers and leaders.
The duties of the Scientific Council are to
HiLIFE Scientific Council 1 June 2022 - 31 December 2026
Invited expert members:
Representatives of HiLIFE Units’ Scientific Advisory Boards (SAB) (until 31.12.2022, new representatives from newly appointed SABs are expected to join the Council in 2023)
The FIMM SAB consists of seven internationally recognized experts in the institute's fields of research and technological activities.
SAB visits FIMM every two years. Based on the visit and documentation provided beforehand, the SAB prepares an evaluation report.
FIMM SAB for the term 1 January 2023 – 31 December 2026
Institute of Biotechnology SAB for the term 1 January 2023 – 31 December 2026:
Neuroscience Center (NC) SAB for the term 1 January 2023 – 31 December 2026: